Scholars@Duke
Journal cover image

Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.

Publication ,  Journal Article
Graham, SD; Walker, A; Cox, EB; Laszlo, J; Berry, WR; Paulson, DF
Published in: Urology
November 1986
Published version (DOI) Link to item

This prospective randomized study in nonhormonally responsive adenocarcinoma of the prostate shows that response rates to melphalan vs cyclophosphamide groups were virtually identical.

Duke Scholars

David Freeman Paulson
Author David Freeman Paulson Urology

Published In

Urology

DOI

10.1016/0090-4295(86)90074-9

ISSN

0090-4295

Publication Date

November 1986

Volume

28

Issue

5

Start / End Page

404 / 408

Location

United States

Related Subject Headings

  • Vincristine
  • Urology & Nephrology
  • Random Allocation
  • Prostatic Neoplasms
  • Prednisone
  • Methotrexate
  • Melphalan
  • Male
  • Humans
  • Fluorouracil
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Graham, S. D., Walker, A., Cox, E. B., Laszlo, J., Berry, W. R., & Paulson, D. F. (1986). Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma. Urology, 28(5), 404–408. https://doi.org/10.1016/0090-4295(86)90074-9
Graham, S. D., A. Walker, E. B. Cox, J. Laszlo, W. R. Berry, and D. F. Paulson. “Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.” Urology 28, no. 5 (November 1986): 404–8. https://doi.org/10.1016/0090-4295(86)90074-9.
Graham SD, Walker A, Cox EB, Laszlo J, Berry WR, Paulson DF. Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma. Urology. 1986 Nov;28(5):404–8.
Graham, S. D., et al. “Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.” Urology, vol. 28, no. 5, Nov. 1986, pp. 404–08. Pubmed, doi:10.1016/0090-4295(86)90074-9.
Graham SD, Walker A, Cox EB, Laszlo J, Berry WR, Paulson DF. Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma. Urology. 1986 Nov;28(5):404–408.
Journal cover image

Published In

Urology

DOI

10.1016/0090-4295(86)90074-9

ISSN

0090-4295

Publication Date

November 1986

Volume

28

Issue

5

Start / End Page

404 / 408

Location

United States

Related Subject Headings

  • Vincristine
  • Urology & Nephrology
  • Random Allocation
  • Prostatic Neoplasms
  • Prednisone
  • Methotrexate
  • Melphalan
  • Male
  • Humans
  • Fluorouracil